Clinical manifestations of COVID-19 infection in dialysis patients and protective effect of COVID-19 vaccine

[1] Alam MR(2021)Comorbidities might be a risk factor for the incidence of COVID-19: Evidence from a web-based survey Prev Med Rep 21 183-202

[2] Kabir MR(2021)Clinical characteristics, treatment, and outcomes of critically ill patients with COVID-19: a scoping review Mayo Clin Proc 96 1117-1129

[3] Reza S(2020)Nomenclature for kidney function and disease: report of a Kidney Disease: improving Global Outcomes (KDIGO) Consensus Conference Kidney Int 97 e1003-e1017

[4] Huang C(2020)Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study Lancet Glob Health 8 2055-2058

[5] Soleimani J(2012)GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology Lancet 380 449-436

[6] Herasevich S(2020)The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation BMC Nephrol 21 430-1548

[7] Levey AS(2020)Factors associated with COVID-19-related death using OpenSAFELY Nature 584 1540-198

[8] Eckardt KU(2020)Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe Kidney Int 98 190-126

[9] Dorman NM(2021)Epidemiology of COVID-19 infection in hospitalized end-stage kidney disease patients in a predominantly African-American population Am J Nephrol 52 117-326

[10] Clark A(1975)Formate assay in body fluids: application in methanol poisoning Biochem Med 13 323-177

[1] Alam MR(2021)Comorbidities might be a risk factor for the incidence of COVID-19: Evidence from a web-based survey Prev Med Rep 21 183-202

[2] Kabir MR(2021)Clinical characteristics, treatment, and outcomes of critically ill patients with COVID-19: a scoping review Mayo Clin Proc 96 1117-1129

[3] Reza S(2020)Nomenclature for kidney function and disease: report of a Kidney Disease: improving Global Outcomes (KDIGO) Consensus Conference Kidney Int 97 e1003-e1017

[4] Huang C(2020)Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study Lancet Glob Health 8 2055-2058

[5] Soleimani J(2012)GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology Lancet 380 449-436

[6] Herasevich S(2020)The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation BMC Nephrol 21 430-1548

[7] Levey AS(2020)Factors associated with COVID-19-related death using OpenSAFELY Nature 584 1540-198

[8] Eckardt KU(2020)Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe Kidney Int 98 190-126

[9] Dorman NM(2021)Epidemiology of COVID-19 infection in hospitalized end-stage kidney disease patients in a predominantly African-American population Am J Nephrol 52 117-326

[10] Clark A(1975)Formate assay in body fluids: application in methanol poisoning Biochem Med 13 323-177